Loading…
Potent Cytotoxic C-11 Modified Geldanamycin Analogues
17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters...
Saved in:
Published in: | Journal of medicinal chemistry 2009-05, Vol.52 (10), p.3265-3273 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183 |
---|---|
cites | cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183 |
container_end_page | 3273 |
container_issue | 10 |
container_start_page | 3265 |
container_title | Journal of medicinal chemistry |
container_volume | 52 |
creator | Tian, Zong-Qiang Wang, Zhan MacMillan, Karen S Zhou, Yiqing Carreras, Christopher W Mueller, Thomas Myles, David C Liu, Yaoquan |
description | 17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG. |
doi_str_mv | 10.1021/jm900098v |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67262869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67262869</sourcerecordid><originalsourceid>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</originalsourceid><addsrcrecordid>eNpt0M1Kw0AUBeBBFFurC19AslFwEb3zl0yWJWgVKrrQdZjO3JGUJFMzidi3N9LQblzdzcc53EPIJYU7Cozer-sMADL1fUSmVDKIhQJxTKYAjMUsYXxCzkJYD4ZTxk_JhGYCpGRqSuSb77Dponzb-c7_lCbKY0qjF29LV6KNFlhZ3eh6a8ommje68p89hnNy4nQV8GK8M_Lx-PCeP8XL18VzPl_GmgvexYphJlJMDUrrhLUAUjtcKQdgnXJCrlIhOArFVQIq4SZlgiVoLTeZTaniM3Kzy920_mvo7Yq6DAarSjfo-1Ak6fCdSrIB3u6gaX0ILbpi05a1brcFheJvo2K_0WCvxtB-VaM9yHGUAVyPQAejK9fqxpRh7xiVNEk5HJw2oVj7vh3mCf8U_gLkSnih</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67262869</pqid></control><display><type>article</type><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</creator><creatorcontrib>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</creatorcontrib><description>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm900098v</identifier><identifier>PMID: 19405528</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Benzoquinones - chemistry ; Benzoquinones - pharmacology ; Biological and medical sciences ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Esters ; General aspects ; HSP90 Heat-Shock Proteins - antagonists & inhibitors ; HSP90 Heat-Shock Proteins - metabolism ; Humans ; Lactams, Macrocyclic - chemistry ; Lactams, Macrocyclic - pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Prodrugs - chemistry ; Protein Binding ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2009-05, Vol.52 (10), p.3265-3273</ispartof><rights>Copyright © 2009 American Chemical Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</citedby><cites>FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21516730$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19405528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tian, Zong-Qiang</creatorcontrib><creatorcontrib>Wang, Zhan</creatorcontrib><creatorcontrib>MacMillan, Karen S</creatorcontrib><creatorcontrib>Zhou, Yiqing</creatorcontrib><creatorcontrib>Carreras, Christopher W</creatorcontrib><creatorcontrib>Mueller, Thomas</creatorcontrib><creatorcontrib>Myles, David C</creatorcontrib><creatorcontrib>Liu, Yaoquan</creatorcontrib><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Benzoquinones - chemistry</subject><subject>Benzoquinones - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Esters</subject><subject>General aspects</subject><subject>HSP90 Heat-Shock Proteins - antagonists & inhibitors</subject><subject>HSP90 Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>Lactams, Macrocyclic - chemistry</subject><subject>Lactams, Macrocyclic - pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prodrugs - chemistry</subject><subject>Protein Binding</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpt0M1Kw0AUBeBBFFurC19AslFwEb3zl0yWJWgVKrrQdZjO3JGUJFMzidi3N9LQblzdzcc53EPIJYU7Cozer-sMADL1fUSmVDKIhQJxTKYAjMUsYXxCzkJYD4ZTxk_JhGYCpGRqSuSb77Dponzb-c7_lCbKY0qjF29LV6KNFlhZ3eh6a8ommje68p89hnNy4nQV8GK8M_Lx-PCeP8XL18VzPl_GmgvexYphJlJMDUrrhLUAUjtcKQdgnXJCrlIhOArFVQIq4SZlgiVoLTeZTaniM3Kzy920_mvo7Yq6DAarSjfo-1Ak6fCdSrIB3u6gaX0ILbpi05a1brcFheJvo2K_0WCvxtB-VaM9yHGUAVyPQAejK9fqxpRh7xiVNEk5HJw2oVj7vh3mCf8U_gLkSnih</recordid><startdate>20090528</startdate><enddate>20090528</enddate><creator>Tian, Zong-Qiang</creator><creator>Wang, Zhan</creator><creator>MacMillan, Karen S</creator><creator>Zhou, Yiqing</creator><creator>Carreras, Christopher W</creator><creator>Mueller, Thomas</creator><creator>Myles, David C</creator><creator>Liu, Yaoquan</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090528</creationdate><title>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</title><author>Tian, Zong-Qiang ; Wang, Zhan ; MacMillan, Karen S ; Zhou, Yiqing ; Carreras, Christopher W ; Mueller, Thomas ; Myles, David C ; Liu, Yaoquan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Benzoquinones - chemistry</topic><topic>Benzoquinones - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Esters</topic><topic>General aspects</topic><topic>HSP90 Heat-Shock Proteins - antagonists & inhibitors</topic><topic>HSP90 Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>Lactams, Macrocyclic - chemistry</topic><topic>Lactams, Macrocyclic - pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prodrugs - chemistry</topic><topic>Protein Binding</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Zong-Qiang</creatorcontrib><creatorcontrib>Wang, Zhan</creatorcontrib><creatorcontrib>MacMillan, Karen S</creatorcontrib><creatorcontrib>Zhou, Yiqing</creatorcontrib><creatorcontrib>Carreras, Christopher W</creatorcontrib><creatorcontrib>Mueller, Thomas</creatorcontrib><creatorcontrib>Myles, David C</creatorcontrib><creatorcontrib>Liu, Yaoquan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Zong-Qiang</au><au>Wang, Zhan</au><au>MacMillan, Karen S</au><au>Zhou, Yiqing</au><au>Carreras, Christopher W</au><au>Mueller, Thomas</au><au>Myles, David C</au><au>Liu, Yaoquan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potent Cytotoxic C-11 Modified Geldanamycin Analogues</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2009-05-28</date><risdate>2009</risdate><volume>52</volume><issue>10</issue><spage>3265</spage><epage>3273</epage><pages>3265-3273</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>17-Allylamino-17-demethoxygeldanamycin (17-AAG) inhibits the activity of Hsp90, an important target for treatment of cancers. In an effort to identify analogues of geldanamycin (GDM) with properties superior to those of 17-AAG, we synthesized C-11 modified derivatives of GDM including ethers, esters, carbazates, ketones, and oximes and measured their affinity for Hsp90 and their ability to inhibit growth of human cancer cells. In accordance with crystal structures reported for complexes of GDMs with Hsp90, bulky groups attached to C-11 interfered with Hsp90 binding while smaller groups such as 11-O-methyl allowed Hsp90 binding. In addition, these analogues also showed in vitro cytotoxicity against human cancer cell lines. Esterfication of the 11-OH of 17-AAG eliminated Hsp90 binding in vitro. The readily hydrolyzed esters acted as prodrugs during the measurement of cytotoxicity. Thus, during these experiments, the esters were hydrolyzed, releasing 17-AAG. Several 11-O-methyl-17-alkylaminogeldanamycin analogues were identified with improved potency relative to 17-AAG.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19405528</pmid><doi>10.1021/jm900098v</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2009-05, Vol.52 (10), p.3265-3273 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_67262869 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Antineoplastic agents Antineoplastic Agents - chemical synthesis Antineoplastic Agents - pharmacology Benzoquinones - chemistry Benzoquinones - pharmacology Biological and medical sciences Cell Line, Tumor Cell Proliferation - drug effects Esters General aspects HSP90 Heat-Shock Proteins - antagonists & inhibitors HSP90 Heat-Shock Proteins - metabolism Humans Lactams, Macrocyclic - chemistry Lactams, Macrocyclic - pharmacology Medical sciences Pharmacology. Drug treatments Prodrugs - chemistry Protein Binding Structure-Activity Relationship |
title | Potent Cytotoxic C-11 Modified Geldanamycin Analogues |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A05%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potent%20Cytotoxic%20C-11%20Modified%20Geldanamycin%20Analogues&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Tian,%20Zong-Qiang&rft.date=2009-05-28&rft.volume=52&rft.issue=10&rft.spage=3265&rft.epage=3273&rft.pages=3265-3273&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm900098v&rft_dat=%3Cproquest_cross%3E67262869%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a343t-82e947e7ce5df4dd005afeb8f00df8f45b7443e483860863c72426edd3c9d7183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67262869&rft_id=info:pmid/19405528&rfr_iscdi=true |